Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$111.4M
-28.6% from 2023
Prescriptions
1.2M
$89.23 per claim
Patients
301K
112,217 prescribers
Total spending, 2024
$111.4M
$370.17 per patient
Medicare prescription drug plans paid $111.4M for Ranolazine Er in 2024, for 1,248,466 prescriptions and refills to 300,957 patients (down 28.6% from 2023). The average cost per claim was $89.23.
Texas had the highest Medicare cost for Ranolazine Er in 2024: $10.1M for 105,032 claims, followed by Florida ($9.3M).
Dan V Dang, cardiology in San Jose, CA, had the highest Medicare cost for Ranolazine Er in 2024: 1,200 claims costing $140K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Dan V Dang San Jose, CA | Cardiology | 1,200 | 357 | $140K |
| Prakash D Shah Milwaukee, WI | Cardiology | 1,191 | 323 | $136K |
| Chau D Nguyen Houston, TX |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 100,245 | 1,081,078 | 256,577 | $165.6M |
| 2023 | 105,261 | 1,136,047 | 273,488 | $156.1M |
| 2024 | 112,217 | 1,248,466 | 300,957 | $111.4M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 472 |
| 154 |
| $121K |
| Henry C Yee Alhambra, CA | Cardiology | 1,616 | 351 | $108K |
| Venkat R Battula Lima, OH | Cardiology | 953 | 289 | $92K |
| Harry Balian Glendale, CA | Cardiology | 1,936 | 259 | $90K |
| Steven Le Fountain Valley, CA | Cardiology | 1,596 | 322 | $89K |
| Dannis E Hood Ringgold, GA | Interventional Cardiology | 930 | 263 | $84K |
| Thomas Mathews Brooksville, FL | Cardiology | 675 | 199 | $80K |
| Harikrishnan Damodaran Nair Glasgow, KY | Cardiology | 1,482 | 374 | $78K |
| Dakshesh-Kumar R Parikh Victoria, TX | Cardiology | 1,158 | 270 | $77K |
| David H Lau New York, NY | Cardiology | 1,827 | 284 | $74K |
| Soni J Zacharias Oklahoma City, OK | Interventional Cardiology | 888 | 234 | $70K |
| Samir Mewar Columbus, GA | Cardiology | 648 | 207 | $69K |
| Shahid I Khan Memphis, TN | Cardiology | 435 | 180 | $68K |
| Michael C Casciello New Bern, NC | Cardiology | 871 | 218 | $67K |
| Salman Ashfaq Gainesville, GA | Cardiology | 752 | 241 | $67K |
| Nasser S Tehrani Perry, GA | Interventional Cardiology | 612 | 217 | $66K |
| Ravichandra R Boyella Montgomery, AL | Cardiology | 541 | 184 | $66K |
| Loi P Nguyen Houston, TX | Cardiology | 506 | 161 | $64K |
| Shi-CHI Cheng Huntsville, AL | Cardiology | 471 | 139 | $63K |
| Kishor N Vora Owensboro, KY | Interventional Cardiology | 729 | 197 | $63K |
| Mauricio Melhado West Palm Beach, FL | Cardiology | 948 | 223 | $63K |
| Ayman Karkoutly Lubbock, TX | Internal Medicine | 960 | 254 | $61K |
| John I Nwogu Anniston, AL | Cardiology | 530 | 178 | $56K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Ajanta Pharma L AJANTPHARM.NS | 371,243 | $30.8M |
| Viona Pharmaceu | 291,435 | $29.0M |
| Camber Pharmace | 221,983 | $20.1M |
| Sciegen Pharmac | 124,687 | $11.7M |
| Lifestar Pharma | 74,980 | $7.3M |
| Ascend Laborato ALKEM.NS | 26,530 | $3.0M |
| Sun Pharmaceuti SUNPHARMA.NS | 44,200 | $2.8M |
| Glenmark Pharma GLENMARK.NS | 20,356 | $2.0M |
| I3 Pharmaceutic | 31,532 | $2.0M |
| Aurobindo Pharm AUROPHARMA.NS | 22,095 | $1.4M |
| Westminster Pha | 10,412 | $797K |
| Actavis/Teva TEVA | 7,896 | $450K |
| Laurus Labs Lim LAURUSLABS.NS | 814 | $61K |
| Micro Labs USA, | 455 | $24K |
| Avkare | 165 | $13K |